An employee works in Moldiag, a biotechnology startup, while producing mpox tests, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)
A view of mpox test kits is displayed in Moldiag, a biotechnology startup, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)
An employee works in Moldiag, a biotechnology startup, while producing mpox tests, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)
Abdeladim Moumem, founder and Chief Scientific Officer of Moldiag, poses for a portrait while producing mpox tests, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)
Imane Abdellaoui Maane works in Moldiag, a biotechnology startup, while producing mpox tests, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)
Imane Abdellaoui Maane works in Moldiag, a biotechnology startup, while producing mpox tests, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)
A view of mpox test kits is displayed in Moldiag, a biotechnology startup, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)
Employees work in Moldiag, a biotechnology startup, while producing mpox tests, in Tamesna, Morocco, Thursday, Nov. 28, 2024. (AP Photo/Mosa'ab Elshamy)